MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Deep brain stimulation (DBS)"

  • 2019 International Congress

    Symptomatic delayed-onset edema following deep brain stimulation for Parkinson’s disease: occurrence, symptoms, management and outcomes. Experience of a single center.

    B. Minafra, NG. Pozzi, M. Picascia, R. Zangaglia, F. Bruschi, F. Avantaggiato, M. Todisco, D. Servello, C. Pacchetti (Pavia, Italy)

    Objective: To report on occurrence, symptoms, management and outcomes of SDE following DBS of either the subthalamic nucleus (STN) or Globus pallidum interna nucleus (GPi)…
  • 2019 International Congress

    Apraxia of Eye Lid Opening in patients with advanced Parkinson’s disease undergoing subthalamic stimulation – a single-centre experience.

    K. Shetty, S. Krishan, K. Kesavapisharady, D. Puthenveedu, A. Kishore (Thiruvananthapuram, India)

    Objective: We aimed to assess the cumulative incidence of apraxia of eye lid opening (AOELO) in patients who have undergone bilateral subthalamic nucleus deep brain…
  • 2019 International Congress

    Outcomes of a Prospective, Multicenter, International Registry of Deep Brain Stimulation for Parkinson’s Disease

    J. Vesper, R. Jain, A. Wang, H. Scholtes, V. Study Group, G. Deuschl (Düsseldorf, Germany)

    Objective: To describe collected outcomes from a large-scale registry of a Deep Brain Stimulation (DBS) system capable of Multiple Independent Current Source Control (MICC) used…
  • 2019 International Congress

    Comparison of Current DBS Platforms in the United States

    L. Surillo, U. Yazdani, S. Chitnis (Dallas, TX, USA)

    Objective: To compare and contrast the currently available deep brain stimulation (DBS) platforms in the United States, their technical features, capabilities and practicality of usage.…
  • 2019 International Congress

    Dynamics of Device-based Treatments for Parkinson´s Disease in Germany from 2010 – 2017

    L. Tönges, D. Bartig, C. Krogias, D. Richter (Bochum, Germany)

    Objective: Analyze the patient profiles and dynamics of utilization of Continuous Subcutaneous Apomorphine Infusion (CSAI), Levodopa-carbidopa Intestinal Gel (LCIG), and Deep Brain Stimulation (DBS) for…
  • 2019 International Congress

    Changes in close relationships among patients with Parkinson’s disease and their partners following initiation of device-aided treatment

    J. Timpka, M. Scharfenort, T. Sahlström, V. Hernström, T. Henriksen, D. Nyholm, P. Odin (Lund, Sweden)

    Objective: Our primary objective was to study whether there is a difference in how close relationships are perceived by Parkinson’s disease (PD) patients with device-aided…
  • 2019 International Congress

    Patient-Centered Outcomes of Deep Brain Stimulation in Parkinson’s Disease

    R. Moraes, J. Freitas, R. Ferreira, P. Pereira, P. Terzian, F. Godinho, M. Rocha (Sao Paulo, Brazil)

    Objective: To evaluate patient-centered outcomes after deep brain stimulation in Parkinson's disease. Background: Deep brain stimulation (DBS) is an effective treatment for Parkinson's disease (PD) patients. Long-term…
  • 2019 International Congress

    Directional lead local field potentials show distinct spatial resolution

    J. Jimenez-Shahed, M. Ozturk, A. Viswanathan, S. Sheth, N. Ince (Houston, TX, USA)

    Objective: To characterize the spatio-spectral patterns of local field potentials (LFPs) in the subthalamic nucleus (STN) recorded from segmented DBS electrodes. Background: PD patients in…
  • 2019 International Congress

    Two Patients with Dopamine Transporter Deficiency Treated with Deep Brain Stimulation

    J. Maclean, D. Ferman, T. Sanger, A. Tongol (Los Angeles, CA, USA)

    Objective: Dopamine transporter deficiency syndrome (DTDS,) a rare disease characterized by infantile –onset progressive dystonia, has no established treatment guidelines.  Treatment is generally predicated on…
  • 2019 International Congress

    Subthalamic Nucleus of Luys: A review. What has evolved since 1865?

    G. Froehner, A. Meira, F. Germiniani, M. Meneses, R. Munhoz, H. Teive (Curitiba, Brazil)

    Objective: The review provides detailed material about the Subthalamic Nucleus of Luys, including pathophisiolgy, hystorical notes about Luys, embryology, anatomy, principal afferents and efferents pathways, as…
  • « Previous Page
  • 1
  • …
  • 97
  • 98
  • 99
  • 100
  • 101
  • …
  • 169
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Comorbid Normal Pressure Hydrocephalus with Parkinson’s disease: a call for clinical awareness
  • Common mistakes in the MoCA test in patients with Parkinson’s Disease in Kyrgyzstan
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley